Clinical Trial Update: Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for post-exposure prophylaxis/preemptive therapy targeting SARS-CoV-2; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease
• Respiratory Distress Syndrome
• Sars-cov Infection

Snippet

Sponsor: University of Minnesota | Conditions: Corona Virus Infection, Acute Respiratory Distress Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2021-05-13